- Home
- CDNA vs MYI Comparison
CDNA vs MYI Comparison
Compare CDNA & MYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- MYI
- Stock Information
- Founded
- CDNA 1998
- MYI 1992
- Country
- CDNA United States
- MYI United States
- Employees
- CDNA N/A
- MYI N/A
- Industry
- CDNA Medical Specialities
- MYI Investment Bankers/Brokers/Service
- Sector
- CDNA Health Care
- MYI Finance
- Exchange
- CDNA Nasdaq
- MYI Nasdaq
- Market Cap
- CDNA 712.2M
- MYI 701.9M
- IPO Year
- CDNA 2014
- MYI N/A
- Fundamental
- Price
- CDNA $13.82
- MYI $10.68
- Analyst Decision
- CDNA Buy
- MYI
- Analyst Count
- CDNA 7
- MYI 0
- Target Price
- CDNA $27.67
- MYI N/A
- AVG Volume (30 Days)
- CDNA 1.5M
- MYI 256.7K
- Earning Date
- CDNA 11-03-2025
- MYI 01-01-0001
- Dividend Yield
- CDNA N/A
- MYI 4.81%
- EPS Growth
- CDNA N/A
- MYI N/A
- EPS
- CDNA 1.00
- MYI N/A
- Revenue
- CDNA $340,826,000.00
- MYI N/A
- Revenue This Year
- CDNA $13.02
- MYI N/A
- Revenue Next Year
- CDNA $12.85
- MYI N/A
- P/E Ratio
- CDNA $13.85
- MYI N/A
- Revenue Growth
- CDNA 14.72
- MYI N/A
- 52 Week Low
- CDNA $10.96
- MYI $9.32
- 52 Week High
- CDNA $32.97
- MYI $11.70
- Technical
- Relative Strength Index (RSI)
- CDNA 54.96
- MYI 64.79
- Support Level
- CDNA $12.37
- MYI $10.54
- Resistance Level
- CDNA $14.20
- MYI $10.60
- Average True Range (ATR)
- CDNA 0.73
- MYI 0.07
- MACD
- CDNA 0.27
- MYI 0.01
- Stochastic Oscillator
- CDNA 87.02
- MYI 100.00
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About MYI Blackrock MuniYield Quality Fund III Inc
BLACKROCK MUNIYIELD QUALITY FUND III, INC. is a investment management company. Its investment objective is to provide shareholders with a high level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in various sectors such as Transportation; Utilities; Health; Education; Tobacco and others.